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Abstract
Background: There are many confirmed risk factors for development of the colorectal cancer,
which is one of the most common malignant tumor among both females and males. Moreover, it
is a cause of significant percentage of all cancer-related deaths. Even with treatment, the 5-year
survival rate is very low. We concentrate on impact of artificial sweeteners on risk and course of
adenocarcinoma of colon. 
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Results:  In  recent  years,  consumption  of  low-calorie  and calorie-free  sweeteners  (LCS) has
increased. It may be caused by campaigns promoting obesity fighting, low calorie drinks, diets,
as well as by increase of social awareness regarding negative health associations associated with
high sugar consumption.
We can divide LCS into two main groups: semi-synthetic and synthetic sweeteners. Substances
from the first  group are homogeneous,  however  those from the second group have different
physical and chemical properties, due to different structure.
LCS quickly gained a lot of interest and scientists are still questioning their safety, especially
during  prolonged use.  Many studies have shown no link between LCS and carcinogenesis,
however there are few studies concerning artificial sweeteners and colon cancer connection.
Discussion: It is important to remember that there are many dietary habits that are connected to
development  of  colorectal  adenocarcinoma.  It  is  difficult  to  assess  the  effect  of  sweeteners
separately. 
Conclusions:  The potential connection between LCS and development of colorectal cancer is
not fully examined. Further studies of this correlation should be conducted.
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Introduction
The colorectal cancer is the most frequent malignancy of the gastrointestinal tract and is
the most significant contributor to morbidity and mortality around the world. Every year in the
USA  there  are  more  than  130,000  new cases  and  55,000  deaths  associated  with  colorectal
adenocarcinoma. This constitutes about 15% of all cancer-related deaths, only lung cancer has
greater mortality. Adenocarcinoma of colon incidence appears the most at 60 to 70 years of age,
in comparison only approximately 20% of patients are 50 or less [1, 2].
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 In Europe it is considered to be the most common malignant tumor. Cancer of the large
intestine (including rectum and anal canal) places second after lung carcinoma in Poland for both
females  and males.  Moreover,  discussed tumor causes about 10 000 deaths per year only in
Poland [3].  The mortality  rate  in  USA is estimated at  60%, however in Poland and Eastern
Europe is significantly higher - about 80% [4].
Even with treatment, the 5-year survival rate is only 20%. Additionally, colorectal cancer
screening  remains  underused which  is  significant  factor  multiplying  mortality.  Colonoscopy,
which is the gold standard for screening of adenocarcinoma of colon should be done every 10
years for people aged 50 or more. Furthermore once a year they need to perform fecal occult
blood test. However, some specialists suggest that even 40- year old men need this laboratory
examination [3].
We can divide  the risk factors  of  colorectal  cancer  into three groups:  environmental,
internal and genetical.  The environmental factors are connected with low intake of vegetable
fiber and high intake of refined sugars and animal fats. Smoking is a major contributor of many
cancers  and also  plays  a  part  in  development  of  colorectal  adenocarcinoma.  Adenomas  and
Crohn’s diseases are examples of the internal ones. Group of genetic risk factors is related to
familial colorectal neoplasia as Gardner syndrome or Classic FAP. Lynch Syndrome 1 and 2 are
the  other  types  of  congenital  factors.  Probability  of  adenocarcinoma  of  colon  in  mentioned
syndromes is about 100% (Lynch syndrome slightly less - 90%) [1, 3, 4].
In  our work we concentrate  on impact  of artificial  sweeteners  on risk and course of
adenocarcinoma of colon. 
 
Frequency and causes of consumption of sweeteners
As an interesting  alternative  to  sugars,  low-calorie  and calorie-free sweeteners  (LCS)
have appeared. Their consumption increases year by year among all age, weight, socioeconomic
and racial-ethnic subgroups. The reasons for consumption of sweeteners are probably related to
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recently carried out campaigns to prevent obesity and increase the popularity of diets aimed at
weight  reduction  by  reducing  the  content  of  carbohydrates  in  the  diet.  The  increase  in  the
popularity of LCS, especially in the elderly, may be the result of an increased incidence of type 2
diabetes in this age group, compared to the other age groups. Another reason for the growing
trend  in  LCS  consumption  in  recent  years  may  be  increase  of  social  awareness  regarding
negative  health  associations  associated  with high sugar consumption.  This could have led to
promotion the transition to drinks and foods containing sweeteners. Studies show that LCS was
more widely used by people with lower weight obesity and chronic illness associated with it, in
people with higher education, higher income and among non-Spaniards [5, 6].
One can expect a further increase in LCS consumption due to campaigns and discussions
concerning the ban on regular carbonated drinks in schools and the taxation of sugar-sweetened
beverages, supported by price differentiation to promote healthier consumer choices. Also, the
frequent incorporation of sweeteners into food and use in "diet" beverages in order to lower the
calorific value of the products sold contributes to the increase in the unconscious consumption of
large amounts of LCS [5].
LCS, despite not providing energy, can affect glucose metabolism, vascular function and
satiety,  as  shown by recent  studies  in  humans  and animals.  Recent  studies  suggest  that  the
preference for sweets is related to the amount of refined sugar consumed and not to the total
sugar  intake  of  the  individual.  The  development  of  preferences  for  highly  sweet  food  and
beverages  can be  caused by repetitive  exposure to  sweet  substances  (those who drink high-
sweetened  beverages  prefer  sweeter  juice  than  people  from  a  low-consumption  group).  In
particular, young children are susceptible to developing nutritional patterns abounding in high-
calorie foods due to early exposure to very sweet substances [5, 7].
The increase in consumption of LCS containing products was observed in all  income
groups, and according to the state of mass, there was a significant increase in LCS consumption
in all  groups (persons with normal weight,  overweight persons and obese persons). In obese
people, the increase in consumption of any products containing LCS was significantly higher
than in  people with overweight  or normal  weight.  Similarly,  in all  age groups,  a  significant
increase in the consumption of products containing LCS was observed [5].
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A relationship has been noted between the consumption of LCS-containing products and
lifestyle  and  a  better  diet  than  those  who  are  not  LCS consumers.  People  consuming  LCS
achieved higher results at the 2005 HEI (healthy eating index in 2005) compared to those who
did not eat LCS. Consumers of LCS more often practiced recreational  physical activity,  had
lower consumption of empty calories, including solid fats, and also less frequently smoked. It
was also noticed that the consumption of fruit, vegetables, whole grains, meat and beans was
higher in these people. The peak LCS consumption was for people in the 45-74 age group [8].
Consumption  of  LCS  products  is  a  helpful  method  supporting  weight  control  and
contributes to a lower intake of carbohydrates and sugars. Studies have shown that LCS drinkers
have lower insulin levels, lower levels of HbA1c and lower HOMA-IR. It can be concluded that
high  intake  of  LCS  reduces  the  risk  of  fulfilling  pre-diabetic  criteria  and  has  no  negative
relationship with the glycemic response [9].
                   
Chemical composition and structure of sweateners
Sweeteners is heterogeneous group of compounds used in the food industry instead 
sucrose, glucose and fructose. Its demonstrate different physical and chemical properties 
depending on the structure . First group of compounds is semi-synthetic fillers, this group 
includes: Sorbitol, Mannitol, Xylitol, Erythritol. In this group all substances is demonstrated 
similar properties, because all substances is homogeneous. Second group of compound is 
synthetic sweeteners, this group includes: Aspartame, Acesulfame potassium, Sodium cyclamate 
and many other substances less popular. In this group substances is demonstrated different 
physical and chemical properties, because all substances has different structure [10].
1.                  Sorbitol - (2R,3R,4R,5S)-hexane-1,2,3,4,5,6-hexol (Sorbitol)
Sorbitol is natural sugar alcohol (polyhydric alcohol, polyalcohols, alditols or glycticos).
Typically it is odorless, noncariogenic, white, crystalline powder of a molecular mass 182,17 g/
mol. Sorbitol sweetness relative to sucrose is 60%. Its solubility in water is 2350 g/l, molecular
formula  is  C6H14O6  [11].  Sorbitol  is  highly  hygroscopic,  resistant  to  hydrolysis  and  high
temperature [12, 13].
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2.                  Mannitol - (2R,3R,4R,5R)-hexane-1,2,3,4,5,6-hexol (Mannitol)
Mannitol chemically is C6H14O6.  Its sweetness relative to sucrose is 50%. Mannitol is
naturally occuring in sea algae, fresh mushrooms and exudates from trees (hence the name "brich
sugar"). It is isomer of sorbitol [14]. Mannitol is white, odorless, crystalline powder of molecular
weight 182,17 g/mol. Its is good soluble in water 216 g/l [15, 16].
3.                  Xylitol - (2S,4R)-pentane-1,2,3,4,5-pentol (Ksylitol)
A five-carbon sugar alcohol derived from xylose by reduction of the carbonyl group. It is
as  sweet  as  sucrose  and used as  a  noncariogenic  sweetener.  Molecular  Formula  is  C5H12O5.
Typically, xylitol is white, crystalline powder, practically odourless, xylitol has molecular weight
152.146 g/mol. Xylitol is very soluble in water 642 g/l [17].
4.                  Erythritol - (2S,3R)-butane-1,2,3,4-tetrol (Erytrytol)
Erythritol is a white, odorless, non-hygroscopic substance and is is soluble in water 610
g/l. Molecular weight of erythritol is 122.12 g/mol and it have sweetness of approximately 60-
80% that of sucrose. Molecular Formula is C4H10O4 [18].
5.                  Acesulfame potassium - potassium;6-methyl-2,2-dioxo-1-oxa-2λ6-thia-3- 
azanidacyclohex-5-en-4-one (Acesulfam K)
Acesulfame  potassium  to  belong  to  sweet  sulfonamides,  it  is  a  potassium  salt.  The
intensity of the sweet taste sensation is determined at the level of 150-200 in relation to sucrose,
so it is more sweet than sucrose approximately 150-200 times sweeter. Acesulfame potassium is
crystalline, odorless and very soluble in aqueous enviroment of 270 g/l [10]. Molecular formula
is C4H4KNO4S. Molecular weight is 201.237 g/mol [19, 20].
6.                  Aspartame-(3S)-3-amino-4-[[(2S)-1-methoxy-1-oxo-3-phenylpropan-2-yl]amino]-4-
oxobutanoic acid (Aspartam)
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Aspartame is the most common sweetener, it is the dipeptid obtained by condensation of
the alpha-carboxyl group of L-aspartic with the amino group of L-phenylalanine. Aspartame has
approximately 200 times more intensity sweet taste than sucrose. Aspartame is characterized the
cleanest tasty and it doesn't leave a bitter taste like the rest of sweeteners. It is not as water-
soluble, thermally stable and chemically stable as other sweeteners. It is poorly soluble in water
13,5 g/l. Molecular weight is 294,307 g/mol. Molecular formula C14H18N2O5 [10, 21].
7.                  Sodium cyclamate - sodium;N-cyclohexylsulfamate                
Sodum  cyclamate  is  30-50  times  more  intensity  sweet  taste  than  sucrose.  It  is
characterized high termally stable and high solublility in water - above 1000 g/l. Odorless or
almost odorless white crystals or crystalline powder. Molecular weight of sodium cyclamate is
201.216  g/mol.  Molecular  Formula  C6H12NNaO3S.  It  is  the  sodium salt  of  cyclamic  acid
(cyclohexanesulfamic acid) [10, 22].
Pathophysiology of large intestinal adenocarcinoma
In western world, colorectal cancer is the most common cause of deaths due to cancers
non-related with smoking and the most common cancer of digestive tract. Its most important
cause might be diet,  especially low-fiber, high-animal fat and poor in vegetables. One of the
most important risk factors is also age- it is low at the age of 40 and starts to increase rapidly at
the  age of  50 and above [23].  Large  intestinal  adenocarcinoma may arise  on the  ground of
adenoma as a result of mutation in gene of APC/beta-katenin tract or microsatellite instability
(MSI) [24]. It tends to be a polypoid, ulcerating or infiltrative, and be annular or constrictive.
Adenocarcinoma locates almost evenly on the whole length of large intestine [23, 24].  
Most common location of primary tumor of large intestinal cancer is rectum (61,3%),
other locations are- sigmoid colon (20,9%), transverse colon (5,7%), ascending colon (4,9%),
caecum (4,1%) and descending colon (3,2%) [25].
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In initial stages the colorectal cancer is clinically silent or gives non-specific symptoms,
like pain in the abdomen, flatulence, red or occur blood which may appear in stool (typical for
right side cancers) and changes in peristalsis. However these symptoms are frequently belittled
by patients. In more advanced stages of caecal cancers and cancers of the right side of colon
patients may suffer from weakness and fatigue as chronic bleeding causes the iron deficiency
anemia. The ill also complain about weight loss. The cancer of left side of colon manifests by
alternate constipations and diarrhoea, shrinks, discomfort, nausea, gaseousness, occlusions and
abdominal  pain.  Rectal  cancer is signalled by straining at  stool,  smaller stools, bleeding and
sudden pressure at stool.In the final stages colorectal cancer gives metastasis to the abdominal
wall, causes bladder symptoms, sciatic nerve pain, small intestinal obstruction and ascites [23,
24, 26].
The colorectal cancer tends to invade locally wing to circular growth, but also spreading
by lymphatic tract, blood vessels, to peritoneum and around nerves. Its main metastasis are to
regional lymph nodes, liver and lung, but also to bones, kidneys, suprarenal glands and brain [26,
27].
Reports on the effect of sweetener intake on colorectal cancer
Colorectal cancer is not only among the most commonly diagnosed cancers in the world,
but  also  a  major  cause  of  cancer-related  deaths.  For  decades  extensive  research  has  been
conducted in order to determine colorectal cancer risk factors and help to prevent it. 
As a result it has been proven to have strong associations with many lifestyle and dietary
factors, such as high consumption of sugar, processed meat or saturated fats [28-30]. 
Furthermore  its  incidence  is  significantly  higher  in  economically  developed countries
[30].
Artificial  sweeteners appeared in last few decades and started to gain lots of interest.
Their  consumption  significantly  increased  and  is  still  increasing,  as  they  are  advertised  as
healthier alternative, that can help to lose weight and are also cheaper to manufacture [31]. Since
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artificial sweeteners conquered the market scientists have been questioning their safety and its
possible link to carcinogenesis. 
The debate about potential cancer risk in artificial sweeteners began with 1970s saccharin
study which found increased occurrence of bladder  cancer  in laboratory rats  and early case-
control human research confirmed it [32, 33]. Although larger epidemiological studies 
failed  to  prove  such  a  link  in  humans,  the  possible  risk  of  carcinogenic  effect  of  artificial
sweeteners is still widely debated [34].
Reports about the influence of artificial sweeteners on colon cancer risk are conflicting
and inconclusive. Plenty of studies have shown lack of association between artificial sweeteners
and carcinogenic risk although none of them specifically regarded colon cancer risk. 
However  there  are  three  studies  concerning  artificial  sweeteners  and  colon  cancer
connection.
In one case control study in 2014 artificial sweeteners were observed to have direct link
with colon cancer risk. The study compared 150 patients with colorectal cancer and 300 control
subjects. It was found that the odds of consuming artificial sweeteners are significantly higher
among patients than control group, and it has been established as a third risk factor of colorectal
cancer after consuming red meat and preserved food [35].
Another study was conducted on Caco-2  and HT-29 cells - colon cell lines. The research proved
that  high concentration  of  artificial  sweeteners  can  cause  hyperplasia  of  the  colon cells  and
fragmentation of their DNA [36]. Although the authors of the study have raised a question if it is
not due to the pH changes. Moreover the concentration used on the cell lines is not achievable
after oral administration. The study also mentions the association of cyclamate with metastatic
adenocarcinoma of the colon in non-human primates that was initially found in 2000 research
regarding  carcinogenicity  of  cyclamate  and reviewed in  2004.  However  the  authors  of  both
studies concluded that there is no proof for carcinogenicity of cyclamate, as the tumors appeared
at a rate often observed in monkeys [37, 38].
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The  most  recent  study  shows  positive  correlation  between  consumption  of  artificial
sweeteners and increased recurrence-free survival and overall survival in patients with III stage
colon cancer [39]. The authors hypothesized that the correlation can be caused by reducing the
consumption  of  sugar  sweetened  beverages  which  are  directly  linked  to  cancer  risk  by
substituting them with artificially sweetened ones.
There  are  other  studies  that  assess  general  relationship  between  artificial  sweeteners
consumption  and cancer  occurrence.  For  instance  long-term studies  in  animal  models  found
sucralose  to  be noncarcinogenic  and have no genotoxic  activity  even in  significantly  higher
exposure levels and therefore safe to use as a non-caloric sugar alternative [40, 41]. Another
case-control study indicated that there is no association between artificial sweeteners and the risk
of several types of cancer [42]. Other systematic review that analyzed 599,741 participants has
concluded  that  collected  data  is  inconclusive  to  attest  any  relationship  between  artificial
sweeteners and cancer [34].
There is still concern about long-term effects of artificial sweeteners and further studies
should  be  conducted  in  order  to  determine  safety  of  their  consumption  and  possibility  of
promoting colorectal carcinogenesis.
 
Discussion
 
In the development of colorectal  adenocarcinoma, abnormal eating habits are of great
importance. The influence of artificial sweeteners on the aforementioned cancer was described in
the article, however, one should remember about the occurrence of many products that increase
the risk of getting sick. Saturated fats are often mentioned. As shown in animal models, a diet
high in fat leads to neoplasia in the large intestine to a greater degree than obesity or metabolic
syndrome. Attention was drawn to the fact that people who consume large amounts of fat do not
have to be obese, so there may be cases where a person who is not obese but has poor eating
habits may be more likely to develop cancer of the large intestine than a person suffering from
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for obesity [43]. For the sake of promising results, attempts to do the same project should be
considered,  but  with  replacing  fat  intake  with  artificial  sweeteners  to  see  if  those  who  are
consuming sweeteners who are not obese are more at risk than those who are obese. 
Research conducted by Niku et al. emphasized that Western-type diet (WD), which is
characterized  by high consumption  of  products  rich  in  saturated  fats,  sugar  and its  artificial
substitutes, and low in calcium, vitamin D and fiber, increases the risk of adenocarcinoma in
large intestine. In these studies, WD has been shown to interact with the heterozygous mutation
in the Apc gene, which has led to metabolic and immunological changes in the colon mucosa
[44]. This allowed for a better understanding of the mechanisms leading to the development of
colorectal  cancer,  which  is  affected  by  incorrect  dietary  habits  and  confirmed  previous
assumptions about the importance of diet in the etiology of the cancer in question.
The importance of abnormal eating habits, including the use of artificial sweeteners, in
the development of colorectal adenocarcinoma is demonstrated by the results of research by Liu
et al., where the presence of correlation between microbiome, inflammation and Wnt-signalising
was described. The mentioned factors jointly contribute for cancer within the large intestine [45].
The described correlation should be studied still, but taking into account strictly defined eating
habits,  which  would  allow to  examine  whether  the  use  of  artificial  sweeteners  leads  to  the
development of colorectal cancer through the said mechanism.
Due to the fact that cancer in the large intestine is becoming more common in the world,
intensive measures should be taken to stop growth trends. It may be helpful to observe that there
are  geographical  differences  in  the  incidence  of  colorectal  adenocarcinoma,  which  may  be
associated with differences in dietary habits in different areas. These conclusions suggest the
possibility of finding a diet or individual products that reduce the risk of developing the cancer in
question. A lot of research has already been carried out to find these types of products, which has
resulted in the isolation of substances known as nutraceuticals that are used in chemoprevention
of cancer in the large intestine. These include stilbenes (from grapes and red wine), isoflavones
(from  soy),  carotenoids  (from  tomatoes),  curcuminoids  (from spice  turmeric)  and  catechins
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(from green tea) [46]. The intake of these compounds can be considered with regular use of
artificial sweeteners to reduce the risk of developing colorectal adenocarcinoma.
Conclusions
Colorectal cancer is a common type of cancers especially in developed countries [47]. On
global scale more than 1 million persons will get colorectal cancer every year. In spite of the use
of new generations  medicines for treatment this type of cancer in the last years cure rates persist
low [48].
In recent years, sweeteners have become increasingly popular in the diet in developed countries
[36].  They  are  used  as  replacements  for  sweet  taste  without  increasing  calorie  intake  [49].
Although they are considered safe, there are data that sweeteners can affect the development of
colon cancer [36].
However, we would like to emphasize that scientific data are ambiguous and contradictory and
require further verification because the potential mechanisms affecting artificial sweeteners on
the development of colorectal cancer have not been fully explained. Therefore further studies
should be conducted.
References
1. Kumar V., Abbas K. A., Aster J.C., Robbins Basic Pathology, Elsevier Saunders, 2013, 596-
599.
2. Hamilton S. R., Bosman F. T., Boffetta P., Carcinoma of the colon and rectum. In:  WHO
Classification of Tumours of the Digestive System. Bosman F. T., Carneiro F., Hruban R. H.,
Theise N. D., IARC Press, Lyon 2010, 134-136.
3. Kordek R., Jassem J.  Onkologia. Podręcznik dla studentów i lekarzy. Via Medica, Gdańsk
2013, 179-183.
1003
4.  Kułakowski  A.,  Skowroński-Gardas  A.  Onkologia.  Podręcznik  dla  studentów  medycyny.
Wydawnictwo Lekarskie PZWL, Warszawa 2017, 147-149.
5.  Sylvetsky  A.  C.,  Welsh  J.  A.,  Brown  R.  J.,  Vos  M.  B.  (2012) Low-calorie  sweetener
consumption is increasing in the United States. The American Journal of Clinical Nutrition,  96
(3), 640–646.
6. Drewnowski A., Rehm C. D. (2015) Socio-demographic correlates and trends in low-calorie
sweetener  use  among adults  in  the  United  States  from 1999 to  2008.  European Journal  of
Clinical Nutrition, 69, 1035–1041.
7. Mahar A., Duizer L.  M.  (2007)  The  Effect  of  Frequency  of  Consumption  of  Artificial
Sweeteners on Sweetness Liking by Women. Journal of Food Science, 72 (9), 714-718.
8. Drewnowski A., Rehm C. D. (2014)  Consumption of Low-Calorie Sweeteners among U.S.
Adults Is Associated with Higher Healthy Eating Index (HEI 2005) Scores and More Physical
Activity. Nutrients, 6 (10), 4389-4403.
9. Leahy M., Ratliff J.  C., Riedt C.  S., Fulgoni V.  L.  (2017)  Consumption  of  Low-Calorie
Sweetened Beverages Compared to Water Is Associated with Reduced Intake of Carbohydrates
and Sugar, with No Adverse Relationships to Glycemic Responses: Results from the 2001–2012
National Health and Nutrition Examination Surveys. Nutrients, 9 (9), 928.
10.  Świerczek U.,  Borowiecka  A.,  Feder-Kubis  J.  (2016) Struktura,  właściwości  i  przykłady
zastosowań  syntetycznych  substancji  słodzących.  Żywność.  Nauka.  Technologia.  Jakość,  4
(107), 15-25.
11. Marques C., Tarek R., Sara M., Brar S. K. (2016) Sorbitol Production From Biomass and Its
Global Market. Platform Chemical Biorefinery, 1, 217–227.
12.  Kowalowski  P.,  Kowalowska  M.,  Stanowska  K.,  Burczyk  J.  (2004)  Naturalne  środki
słodzące w świetle dopuszczalności ich spożycia w Polsce i krajach Unii Europejskiej.  Postępy
fitoterapii, 1, 4-9.
1004
13. National Center for Biotechnology Information.  PubChem Database.  Sorbitol, CID=5780,
https://pubchem.ncbi.nlm.nih.gov/compound/Sorbitol (accessed on Sept. 6, 2019).
14. Shawkat H., Westwood MM., Mortimer A. (2012) Mannitol: a review of its clinical uses.
Continuing Education in Anaesthesia Critical Care & Pain, 12 (2), 82-85.
15. National Center for Biotechnology Information. PubChem Database. Mannitol, CID=6251,
https://pubchem.ncbi.nlm.nih.gov/compound/Mannitol (accessed on Sept. 6, 2019).
16.  Livesey G.  (2003) Health  potential  of  polyols  as  sugar  replacers  with emphasis  on low
glycaemic properties. Nutrition Research Reviews, 16 (2), 163-191.
17.  National  Center  for  Biotechnology  Information.  PubChem Database.  Xylitol,  CID=6912,
https://pubchem.ncbi.nlm.nih.gov/compound/Xylitol (accessed on Sept. 6, 2019).
18.  National  Center  for  Biotechnology  Information.  PubChem  Database.  Erythritol,
CID=222285,  https://pubchem.ncbi.nlm.nih.gov/compound/Erythritol  (accessed  on  Sept.  6,
2019).
19. National Center for Biotechnology Information. PubChem Database. Acesulfame potassium,
CID=11074431,  https://pubchem.ncbi.nlm.nih.gov/compound/Acesulfame-potassium  (accessed
on Sept. 6, 2019).
20.National  Center  for  Biotechnology  Information.  PubChem  Database.  Acesulfame,
CID=36573,  https://pubchem.ncbi.nlm.nih.gov/compound/Acesulfame  (accessed  on  Sept.  6,
2019).
21.   National  Center  for  Biotechnology  Information.  PubChem  Database.  Aspartame,
CID=134601,  https://pubchem.ncbi.nlm.nih.gov/compound/Aspartame  (accessed  on  Sept.  6,
2019).
22.   National Center for Biotechnology Information. PubChem Database. Sodium cyclamate,
CID=23665706,  https://pubchem.ncbi.nlm.nih.gov/compound/Sodium-cyclamate  (accessed  on
Sept. 6, 2019).
1005
23. Rubin E., Farber J. L.,  Pathology, Lippincott - Raven Publishers, Philadelphia 1998, 742-
747.
24. Kumar V., Abbas A. K., Aster J. C., Robbins Patologia, Elsevier Urban & Partner, Wrocław
2014, 642-644.
25.  Fuchs  R.,  Guggenberger  D.,  Neumann  U.,  Trautweim  C.,  Nowotwory  przewodu
pokarmowego, Diagnostyka i leczenie, Wydawnictwo Czelej, Lublin 2012, 252.
26.  Pazdur  R.,  Wagman  L.  D.,  Camphausen  K.  A.,  Hoskins  W.  J.,  Nowotwory  złośliwe.
Postępowanie wielodyscyplinarne tom 1, Wydawnictwo Czelej, Lublin 2012, 243-250.
27.  Stachura  J.,  Domagała  W.,  Patologia  znaczy słowo o chorobie tom 2,  Polska Akademia
Umiejętności, Kraków 2009, 837.
28. Benarba B. (2018). Red and processed meat and risk of colorectal cancer: an update. EXCLI
journal, 17, 792..
29. Chen Z., Wang P. P., Woodrow J., Zhu Y., Roebothan B., Mclaughlin J. R., Parfrey P. S.
(2015) Dietary patterns and colorectal cancer: results from a Canadian population-based study.
Nutrition Journal, 14 (1), 8.
30. Azeem S., Gillani  S. W.,  Siddiqui A., Jandrajupalli  S. B., Poh V., Syed Sulaiman S. A.
(2015) Diet and colorectal cancer risk in Asia--A systematic review.  Asian Pacific Journal of
Cancer Prevention, 16 (13), 5389-5396.
31. Sylvetsky A. C., Rother K. I. (2016) Trends in the consumption of low-calorie sweeteners.
Physiology & behavior, 164, 446-450.
32. Price J. M., Biava C. G., Oser B. L., Vogin E. E., Steinfeld J., Ley H. L. (1970). Bladder
tumors  in  rats  fed cyclohexylamine  or  high doses  of  a  mixture  of  cyclamate  and saccharin.
Science, 167 (3921), 1131-1132.
1006
33. Howe G. R., Burch J. D., Miller A. B., et al. (1977). Artificial sweeteners and human bladder
cancer. The Lancet, 310 (8038), 578-581.
34. Mishra A., Ahmed K., Froghi S., Dasgupta P. (2015) Systematic review of the relationship
between  artificial  sweetener  consumption  and  cancer  in  humans:  analysis  of  599,741
participants. International Journal of Clinical Practice, 69 (12), 1418-1426.
35. Mahfouz E. M., Sadek R. R., Abdel-Latief W. M., Mosallem F. A., Hassan E. E. (2014) The
role of dietary and lifestyle factors in the development of colorectal cancer: case control study in
Minia, Egypt. Central European Journal of Public Health, 22 (4), 215-22.
36. van Eyk A. D. (2015) The effect of five artificial sweeteners on Caco-2, HT-29 and HEK-
293 cells. Drug and chemical toxicology, 38 (3), 318-327.
37. Takayama S., Renwick A. G., Johansson S. L., Thorgeirsson U. P., Tsutsumi M., Dalgard D.
W., Sieber S. M. (2000) Long-term toxicity and carcinogenicity study of cyclamate in nonhuman
primates. Toxicological Sciences, 53 (1), 33-39.
38. Weihrauch M. R., Diehl V. (2004) Artificial sweeteners—do they bear a carcinogenic risk?
Annals of Oncology, 15 (10), 1460-1465.
39. Guercio B. J., Zhang S., Niedzwiecki D., et al. (2018). Associations of artificially sweetened
beverage intake with disease recurrence and mortality in stage III colon cancer: Results from
CALGB 89803 (Alliance). PloS one, 13 (7), e0199244.
40. Magnuson B. A., Roberts A., Nestmann E. R. (2017) Critical review of the current literature
on the safety of sucralose. Food and Chemical Toxicology, 106, 324-355.
41.  Berry C.,  Brusic  D.,  Cohen S.  M.,  Hardisty J.  F.,  Grotz  V.  L.,  Williams  G.  M. (2016)
Sucralose non-carcinogenicity: a review of the scientific and regulatory rationale. Nutrition and
cancer, 68 (8), 1247-1261.
42. Gallus S., Scotti L., Negri E., et al. (2006) Artificial sweeteners and cancer risk in a network
of case–control studies. Annals of Oncology, 18 (1), 40-44.
1007
43. Doerner S. K., Reis E. S., Leung E. S. et al.  (2016) High-Fat Diet-Induced Complement
Activation Mediates Intestinal Inflammation and Neoplasia, Independent of Obesity. Molecular
Cancer Research, 14 (10), 953-965.
44.  Niku  M.,  Pajari  A.  M.,  Sarantaus  L.  et  al.  (2017)  Western  diet  enhances  intestinal
tumorigenesis in Min/+ mice, associating with mucosal metabolic and inflammatory stress and
loss of Apc heterozygosity. The Journal of Nutritional Biochemistry, 39, 126-133.
45. Liu W., Crott J. W., Lyu L. et al. (2016) Diet- and Genetically-induced Obesity Produces
Alterations in the Microbiome, Inflammation and Wnt Pathway in the Intestine of Apc+/1638N
Mice: Comparisons and Contrasts. Journal of Cancer, 7 (13), 1780-1790.
46.  Ullah M. F.,  Bhat  S.  H.,  Husain  E.  et  al.  (2016).  Pharmacological  Intervention  through
Dietary  Nutraceuticals  in  Gastrointestinal  Neoplasia.  Critical  Reviews  in  Food  Science  and
Nutrition, 56 (9) 1501-1518.
47. Merika E., Saif M. W., Katz A., Syrigos K., Syrigos C., Morse M. (2010) Review. Colon
cancer vaccines: an update. In Vivo, 24 (5), 607–628.
48. Cunningham D., Atkin W., Lenz H. J., Lynch H. T., Minsky B., Nordlinger B., Starling N.
(2010) Colorectal cancer. Lancet, 375 (9719), 1030–1047.
49. Suez J., Korem, T., Zilberman-Schapira G., Segal E., Elinav E. (2015) Non-caloric artificial
sweeteners and the microbiome: findings and challenges. Gut microbes, 6 (2), 149-155.
1008
